Date: 2014-05-29 15:15:36

Pharmacology

Adalimumab

Psoriasis

Leflunomide

Ustekinumab

Psoriatic arthritis

Etanercept

Golimumab

Infliximab

Immunosuppressants

Medicine

Immunology

PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 80,86 KB